We are investigating how the enzyme tyrosine hydroxylase, the rate-limiting enzyme for dopamine production, is regulated in the healthy brain and how this is changed in Parkinson's disease.
The selective degeneration of A9 dopaminergic neurons in the substantia nigra pars compacta (SNpc) in Parkinson’s disease is well recognised while other dopaminergic cells, such as those found in the
